Simon Pedder
CIK 1316736 · Executive Chairman · last filed 2025-09-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
7
Total Filings
37
Lifetime Open-Market Net
$165.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Athenex, Inc. (ATNX) Delisted | See Remarks | 5,310 | $0.20 | $1.1K | $40.8K | 9 | 2021-08-05 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Executive Chairman of the Bd | 241,833 | $2.93 | $708.6K | $50.4K | 8 | 2020-04-13 |
| DCTH | Director | — | $11.72 | — | $0 | 1 | 2019-02-05 |
| Avalo Therapeutics, Inc. (CERCW) Delisted | Director | — | — | — | $0 | 4 | 2018-10-01 |
| Oncotelic Therapeutics, Inc. (OXGN) Delisted | Director | — | — | — | $0 | 2 | 2016-06-03 |
| Cellectar Biosciences, Inc. (CLRB.W) Delisted | President and CEO | 13,300 | — | — | $49.9K | 1 | 2014-08-22 |
| Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Chief Executive Officer | 488,180 | — | — | $23.9K | 9 | 2012-01-27 |
Recent Filings · Page 2 of 4
37 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-04-01 | Avalo Therapeutics, Inc. (CERC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-05 | Athenex, Inc. (ATNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-04 | Athenex, Inc. (ATNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-05 | DCTH | Grant (A) | — | $0 | EDGAR |
| 2019-01-02 | Avalo Therapeutics, Inc. (CERC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-11-14 | Athenex, Inc. (ATNX) Delisted | Buy (P) | +2,908 | $29.8K | EDGAR |
| 2018-10-01 | Avalo Therapeutics, Inc. (CERCW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-08-21 | Athenex, Inc. (ATNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-07-03 | Avalo Therapeutics, Inc. (CERCW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-22 | — | Grant (A) | — | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.